Apyx Medical (APYX)
(Delayed Data from NSDQ)
$1.09 USD
+0.04 (3.81%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $1.09 0.00 (0.00%) 5:02 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Apyx Medical (APYX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$2.00 | $2.00 | $2.00 | 90.48% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Apyx Medical comes to $2.00. The forecasts range from a low of $2.00 to a high of $2.00. The average price target represents an increase of 90.48% from the last closing price of $1.05.
Analyst Price Targets (2 )
Broker Rating
Apyx Medical currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | JMP Securities | David L Turkaly | Hold | Hold |
9/5/2024 | Stephens | George Sellers | Strong Buy | Strong Buy |
8/9/2024 | Lake Street Capital Markets | Frank Takkinen | Strong Buy | Strong Buy |
8/8/2024 | Piper Sandler | Matthew O'Brien | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 4 |
Average Target Price | $2.00 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 65 of 253 |
Current Quarter EPS Est: | -0.15 |
APYX FAQs
Apyx Medical Corporation (APYX) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Apyx Medical Corporation (APYX) is $2.00. The current on short-term price targets is based on 2 reports.
The forecasts for Apyx Medical Corporation (APYX) range from a low of $2 to a high of $2. The average price target represents a increase of $90.48 from the last closing price of $1.05.
The current UPSIDE for Apyx Medical Corporation (APYX) is 90.48%
Based on short-term price targets offered by two analysts, the average price target for Apyx Medical comes to $2.00. The forecasts range from a low of $2.00 to a high of $2.00. The average price target represents an increase of 90.48% from the last closing price of $1.05.